EUROPEAN JOURNAL OF NEUROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228518, encodeId=f78812285185e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿2个多月拒稿。投稿1天under review，外审2个月左右，中间催过一次，两个多月后拒稿，一个审稿人给了很多意见都比较严谨，还是有很大收获。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a88f5554247, createdName=ms4000000456746938, createdTime=Fri Jun 24 22:19:45 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529775, encodeId=26b4529e75d8, content=请问怎么看出来是没有送审呢？我第三天under review，第四天就awaiting decision，这样有没有外审呢？shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3991697203, createdName=LIU91, createdTime=Thu Nov 24 23:00:00 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518880, encodeId=f22c518880be, content=杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e351684614, createdName=shuozi, createdTime=Fri Jan 29 16:27:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209713, encodeId=4fdf1209e13ed, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第三次投这个杂志了，**次外审一个月拒搞，第二次直接拒搞未送审，这次终于成功接收😁😁😁 2022/2 24 Submit 2022/2 25 Under review 2022/3 15 Awaiting decision 2022/3 17 reject with invitation to resubmit 2022/3 29 Submit 2022/3 30 Under review 2022/4 5 Awaiting decision 2022/4 5 Minor revision 2022/4 7 Submit 2022/4 8 Under review 2022/4 8 Awaiting decision 2022/4 8 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Sat Apr 09 02:06:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083520, encodeId=eeee1083520a9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;基因;临床 经验分享：2021/09/21 Admin Processing 2021/09/22 Under Review 2021/10/11 Awaiting Decision 2021/10/27 催稿信 2021/10/28 杂志社回信 2021/11/05 Major Revision 2021/11/18 Admin Processing 2021/11/19 Under Review 2021/12/15 Awaiting Decision 2021/12/16 Minor Revision 2021/12/21 Admin Processing; Under Review 2021/12/22 Accept; Awaiting Production Checklist; Awaiting Assignment to Batch 2021/12/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 11:58:41 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081037, encodeId=87a1108103eb9, content=无经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Fri Dec 17 08:33:43 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579186, encodeId=c71f5e918696, content=好像收费吧shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/c2753fa357c64d2798acbad1071d0b49/e8ee71151b524eea903a818c41a35e77.png, createdBy=d87f2291021, createdName=121e7464m10暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891825, encodeId=6c378918256b, content=接受非约稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0405423428, createdName=ms7000001459311547, createdTime=Tue Oct 13 18:31:21 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585695, encodeId=4c51585695a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：初审3个月，两个审稿人，一个审稿人没意见，另一个审稿人提的意见也比较中肯，编辑给了大修，一个月后修回，二审1个月直接接收了，不收费的哦，效率还是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30785291681, createdName=1486509fm51(暂无昵称), createdTime=Mon Mar 02 11:56:00 CST 2020, time=2020-03-02, status=1, ipAttribution=)]

2022-04-02 水木清华观自在

审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。

102 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228518, encodeId=f78812285185e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿2个多月拒稿。投稿1天under review，外审2个月左右，中间催过一次，两个多月后拒稿，一个审稿人给了很多意见都比较严谨，还是有很大收获。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a88f5554247, createdName=ms4000000456746938, createdTime=Fri Jun 24 22:19:45 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529775, encodeId=26b4529e75d8, content=请问怎么看出来是没有送审呢？我第三天under review，第四天就awaiting decision，这样有没有外审呢？shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3991697203, createdName=LIU91, createdTime=Thu Nov 24 23:00:00 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518880, encodeId=f22c518880be, content=杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e351684614, createdName=shuozi, createdTime=Fri Jan 29 16:27:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209713, encodeId=4fdf1209e13ed, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第三次投这个杂志了，**次外审一个月拒搞，第二次直接拒搞未送审，这次终于成功接收😁😁😁 2022/2 24 Submit 2022/2 25 Under review 2022/3 15 Awaiting decision 2022/3 17 reject with invitation to resubmit 2022/3 29 Submit 2022/3 30 Under review 2022/4 5 Awaiting decision 2022/4 5 Minor revision 2022/4 7 Submit 2022/4 8 Under review 2022/4 8 Awaiting decision 2022/4 8 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Sat Apr 09 02:06:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083520, encodeId=eeee1083520a9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;基因;临床 经验分享：2021/09/21 Admin Processing 2021/09/22 Under Review 2021/10/11 Awaiting Decision 2021/10/27 催稿信 2021/10/28 杂志社回信 2021/11/05 Major Revision 2021/11/18 Admin Processing 2021/11/19 Under Review 2021/12/15 Awaiting Decision 2021/12/16 Minor Revision 2021/12/21 Admin Processing; Under Review 2021/12/22 Accept; Awaiting Production Checklist; Awaiting Assignment to Batch 2021/12/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 11:58:41 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081037, encodeId=87a1108103eb9, content=无经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Fri Dec 17 08:33:43 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579186, encodeId=c71f5e918696, content=好像收费吧shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/c2753fa357c64d2798acbad1071d0b49/e8ee71151b524eea903a818c41a35e77.png, createdBy=d87f2291021, createdName=121e7464m10暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891825, encodeId=6c378918256b, content=接受非约稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0405423428, createdName=ms7000001459311547, createdTime=Tue Oct 13 18:31:21 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585695, encodeId=4c51585695a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：初审3个月，两个审稿人，一个审稿人没意见，另一个审稿人提的意见也比较中肯，编辑给了大修，一个月后修回，二审1个月直接接收了，不收费的哦，效率还是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30785291681, createdName=1486509fm51(暂无昵称), createdTime=Mon Mar 02 11:56:00 CST 2020, time=2020-03-02, status=1, ipAttribution=)]

2022-06-24 ms4000000456746938

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：帕金森病
经验分享：投稿2个多月拒稿。投稿1天under review，外审2个月左右，中间催过一次，两个多月后拒稿，一个审稿人给了很多意见都比较严谨，还是有很大收获。

53 0

[GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228518, encodeId=f78812285185e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿2个多月拒稿。投稿1天under review，外审2个月左右，中间催过一次，两个多月后拒稿，一个审稿人给了很多意见都比较严谨，还是有很大收获。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a88f5554247, createdName=ms4000000456746938, createdTime=Fri Jun 24 22:19:45 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529775, encodeId=26b4529e75d8, content=请问怎么看出来是没有送审呢？我第三天under review，第四天就awaiting decision，这样有没有外审呢？shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3991697203, createdName=LIU91, createdTime=Thu Nov 24 23:00:00 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518880, encodeId=f22c518880be, content=杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e351684614, createdName=shuozi, createdTime=Fri Jan 29 16:27:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209713, encodeId=4fdf1209e13ed, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第三次投这个杂志了，**次外审一个月拒搞，第二次直接拒搞未送审，这次终于成功接收😁😁😁 2022/2 24 Submit 2022/2 25 Under review 2022/3 15 Awaiting decision 2022/3 17 reject with invitation to resubmit 2022/3 29 Submit 2022/3 30 Under review 2022/4 5 Awaiting decision 2022/4 5 Minor revision 2022/4 7 Submit 2022/4 8 Under review 2022/4 8 Awaiting decision 2022/4 8 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Sat Apr 09 02:06:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083520, encodeId=eeee1083520a9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;基因;临床 经验分享：2021/09/21 Admin Processing 2021/09/22 Under Review 2021/10/11 Awaiting Decision 2021/10/27 催稿信 2021/10/28 杂志社回信 2021/11/05 Major Revision 2021/11/18 Admin Processing 2021/11/19 Under Review 2021/12/15 Awaiting Decision 2021/12/16 Minor Revision 2021/12/21 Admin Processing; Under Review 2021/12/22 Accept; Awaiting Production Checklist; Awaiting Assignment to Batch 2021/12/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 11:58:41 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081037, encodeId=87a1108103eb9, content=无经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Fri Dec 17 08:33:43 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579186, encodeId=c71f5e918696, content=好像收费吧shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/c2753fa357c64d2798acbad1071d0b49/e8ee71151b524eea903a818c41a35e77.png, createdBy=d87f2291021, createdName=121e7464m10暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891825, encodeId=6c378918256b, content=接受非约稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0405423428, createdName=ms7000001459311547, createdTime=Tue Oct 13 18:31:21 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585695, encodeId=4c51585695a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：初审3个月，两个审稿人，一个审稿人没意见，另一个审稿人提的意见也比较中肯，编辑给了大修，一个月后修回，二审1个月直接接收了，不收费的哦，效率还是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30785291681, createdName=1486509fm51(暂无昵称), createdTime=Mon Mar 02 11:56:00 CST 2020, time=2020-03-02, status=1, ipAttribution=)]

2016-11-24 LIU91

请问怎么看出来是没有送审呢？我第三天under review，第四天就awaiting decision，这样有没有外审呢？shuozi 2016-01-29 发表::
杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。

shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。

431 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228518, encodeId=f78812285185e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿2个多月拒稿。投稿1天under review，外审2个月左右，中间催过一次，两个多月后拒稿，一个审稿人给了很多意见都比较严谨，还是有很大收获。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a88f5554247, createdName=ms4000000456746938, createdTime=Fri Jun 24 22:19:45 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529775, encodeId=26b4529e75d8, content=请问怎么看出来是没有送审呢？我第三天under review，第四天就awaiting decision，这样有没有外审呢？shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3991697203, createdName=LIU91, createdTime=Thu Nov 24 23:00:00 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518880, encodeId=f22c518880be, content=杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e351684614, createdName=shuozi, createdTime=Fri Jan 29 16:27:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209713, encodeId=4fdf1209e13ed, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第三次投这个杂志了，**次外审一个月拒搞，第二次直接拒搞未送审，这次终于成功接收😁😁😁 2022/2 24 Submit 2022/2 25 Under review 2022/3 15 Awaiting decision 2022/3 17 reject with invitation to resubmit 2022/3 29 Submit 2022/3 30 Under review 2022/4 5 Awaiting decision 2022/4 5 Minor revision 2022/4 7 Submit 2022/4 8 Under review 2022/4 8 Awaiting decision 2022/4 8 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Sat Apr 09 02:06:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083520, encodeId=eeee1083520a9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;基因;临床 经验分享：2021/09/21 Admin Processing 2021/09/22 Under Review 2021/10/11 Awaiting Decision 2021/10/27 催稿信 2021/10/28 杂志社回信 2021/11/05 Major Revision 2021/11/18 Admin Processing 2021/11/19 Under Review 2021/12/15 Awaiting Decision 2021/12/16 Minor Revision 2021/12/21 Admin Processing; Under Review 2021/12/22 Accept; Awaiting Production Checklist; Awaiting Assignment to Batch 2021/12/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 11:58:41 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081037, encodeId=87a1108103eb9, content=无经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Fri Dec 17 08:33:43 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579186, encodeId=c71f5e918696, content=好像收费吧shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/c2753fa357c64d2798acbad1071d0b49/e8ee71151b524eea903a818c41a35e77.png, createdBy=d87f2291021, createdName=121e7464m10暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891825, encodeId=6c378918256b, content=接受非约稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0405423428, createdName=ms7000001459311547, createdTime=Tue Oct 13 18:31:21 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585695, encodeId=4c51585695a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：初审3个月，两个审稿人，一个审稿人没意见，另一个审稿人提的意见也比较中肯，编辑给了大修，一个月后修回，二审1个月直接接收了，不收费的哦，效率还是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30785291681, createdName=1486509fm51(暂无昵称), createdTime=Mon Mar 02 11:56:00 CST 2020, time=2020-03-02, status=1, ipAttribution=)]

2016-01-29 shuozi

杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。

419 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228518, encodeId=f78812285185e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿2个多月拒稿。投稿1天under review，外审2个月左右，中间催过一次，两个多月后拒稿，一个审稿人给了很多意见都比较严谨，还是有很大收获。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a88f5554247, createdName=ms4000000456746938, createdTime=Fri Jun 24 22:19:45 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529775, encodeId=26b4529e75d8, content=请问怎么看出来是没有送审呢？我第三天under review，第四天就awaiting decision，这样有没有外审呢？shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3991697203, createdName=LIU91, createdTime=Thu Nov 24 23:00:00 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518880, encodeId=f22c518880be, content=杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e351684614, createdName=shuozi, createdTime=Fri Jan 29 16:27:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209713, encodeId=4fdf1209e13ed, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第三次投这个杂志了，**次外审一个月拒搞，第二次直接拒搞未送审，这次终于成功接收😁😁😁 2022/2 24 Submit 2022/2 25 Under review 2022/3 15 Awaiting decision 2022/3 17 reject with invitation to resubmit 2022/3 29 Submit 2022/3 30 Under review 2022/4 5 Awaiting decision 2022/4 5 Minor revision 2022/4 7 Submit 2022/4 8 Under review 2022/4 8 Awaiting decision 2022/4 8 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Sat Apr 09 02:06:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083520, encodeId=eeee1083520a9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;基因;临床 经验分享：2021/09/21 Admin Processing 2021/09/22 Under Review 2021/10/11 Awaiting Decision 2021/10/27 催稿信 2021/10/28 杂志社回信 2021/11/05 Major Revision 2021/11/18 Admin Processing 2021/11/19 Under Review 2021/12/15 Awaiting Decision 2021/12/16 Minor Revision 2021/12/21 Admin Processing; Under Review 2021/12/22 Accept; Awaiting Production Checklist; Awaiting Assignment to Batch 2021/12/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 11:58:41 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081037, encodeId=87a1108103eb9, content=无经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Fri Dec 17 08:33:43 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579186, encodeId=c71f5e918696, content=好像收费吧shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/c2753fa357c64d2798acbad1071d0b49/e8ee71151b524eea903a818c41a35e77.png, createdBy=d87f2291021, createdName=121e7464m10暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891825, encodeId=6c378918256b, content=接受非约稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0405423428, createdName=ms7000001459311547, createdTime=Tue Oct 13 18:31:21 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585695, encodeId=4c51585695a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：初审3个月，两个审稿人，一个审稿人没意见，另一个审稿人提的意见也比较中肯，编辑给了大修，一个月后修回，二审1个月直接接收了，不收费的哦，效率还是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30785291681, createdName=1486509fm51(暂无昵称), createdTime=Mon Mar 02 11:56:00 CST 2020, time=2020-03-02, status=1, ipAttribution=)]

2022-04-09 程莫斯

审稿速度:1.0 | 投稿命中率:25.0
经验分享：第三次投这个杂志了，**次外审一个月拒搞，第二次直接拒搞未送审，这次终于成功接收😁😁😁 2022/2 24 Submit 2022/2 25 Under review 2022/3 15 Awaiting decision 2022/3 17 reject with invitation to resubmit 2022/3 29 Submit 2022/3 30 Under review 2022/4 5 Awaiting decision 2022/4 5 Minor revision 2022/4 7 Submit 2022/4 8 Under review 2022/4 8 Awaiting decision 2022/4 8 Accept

87 0

[GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228518, encodeId=f78812285185e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿2个多月拒稿。投稿1天under review，外审2个月左右，中间催过一次，两个多月后拒稿，一个审稿人给了很多意见都比较严谨，还是有很大收获。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a88f5554247, createdName=ms4000000456746938, createdTime=Fri Jun 24 22:19:45 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529775, encodeId=26b4529e75d8, content=请问怎么看出来是没有送审呢？我第三天under review，第四天就awaiting decision，这样有没有外审呢？shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3991697203, createdName=LIU91, createdTime=Thu Nov 24 23:00:00 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518880, encodeId=f22c518880be, content=杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e351684614, createdName=shuozi, createdTime=Fri Jan 29 16:27:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209713, encodeId=4fdf1209e13ed, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第三次投这个杂志了，**次外审一个月拒搞，第二次直接拒搞未送审，这次终于成功接收😁😁😁 2022/2 24 Submit 2022/2 25 Under review 2022/3 15 Awaiting decision 2022/3 17 reject with invitation to resubmit 2022/3 29 Submit 2022/3 30 Under review 2022/4 5 Awaiting decision 2022/4 5 Minor revision 2022/4 7 Submit 2022/4 8 Under review 2022/4 8 Awaiting decision 2022/4 8 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Sat Apr 09 02:06:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083520, encodeId=eeee1083520a9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;基因;临床 经验分享：2021/09/21 Admin Processing 2021/09/22 Under Review 2021/10/11 Awaiting Decision 2021/10/27 催稿信 2021/10/28 杂志社回信 2021/11/05 Major Revision 2021/11/18 Admin Processing 2021/11/19 Under Review 2021/12/15 Awaiting Decision 2021/12/16 Minor Revision 2021/12/21 Admin Processing; Under Review 2021/12/22 Accept; Awaiting Production Checklist; Awaiting Assignment to Batch 2021/12/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 11:58:41 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081037, encodeId=87a1108103eb9, content=无经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Fri Dec 17 08:33:43 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579186, encodeId=c71f5e918696, content=好像收费吧shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/c2753fa357c64d2798acbad1071d0b49/e8ee71151b524eea903a818c41a35e77.png, createdBy=d87f2291021, createdName=121e7464m10暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891825, encodeId=6c378918256b, content=接受非约稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0405423428, createdName=ms7000001459311547, createdTime=Tue Oct 13 18:31:21 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585695, encodeId=4c51585695a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：初审3个月，两个审稿人，一个审稿人没意见，另一个审稿人提的意见也比较中肯，编辑给了大修，一个月后修回，二审1个月直接接收了，不收费的哦，效率还是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30785291681, createdName=1486509fm51(暂无昵称), createdTime=Mon Mar 02 11:56:00 CST 2020, time=2020-03-02, status=1, ipAttribution=)]

2021-12-23 雪亦飘零久

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：帕金森病;基因;临床
经验分享：2021/09/21 Admin Processing
2021/09/22 Under Review
2021/10/11 Awaiting Decision
2021/10/27 催稿信
2021/10/28 杂志社回信
2021/11/05 Major Revision
2021/11/18 Admin Processing
2021/11/19 Under Review
2021/12/15 Awaiting Decision
2021/12/16 Minor Revision
2021/12/21 Admin Processing; Under Review
2021/12/22 Accept; Awaiting Production Checklist; Awaiting Assignment to Batch
2021/12/23 Accept

66 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228518, encodeId=f78812285185e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿2个多月拒稿。投稿1天under review，外审2个月左右，中间催过一次，两个多月后拒稿，一个审稿人给了很多意见都比较严谨，还是有很大收获。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a88f5554247, createdName=ms4000000456746938, createdTime=Fri Jun 24 22:19:45 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529775, encodeId=26b4529e75d8, content=请问怎么看出来是没有送审呢？我第三天under review，第四天就awaiting decision，这样有没有外审呢？shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3991697203, createdName=LIU91, createdTime=Thu Nov 24 23:00:00 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518880, encodeId=f22c518880be, content=杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e351684614, createdName=shuozi, createdTime=Fri Jan 29 16:27:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209713, encodeId=4fdf1209e13ed, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第三次投这个杂志了，**次外审一个月拒搞，第二次直接拒搞未送审，这次终于成功接收😁😁😁 2022/2 24 Submit 2022/2 25 Under review 2022/3 15 Awaiting decision 2022/3 17 reject with invitation to resubmit 2022/3 29 Submit 2022/3 30 Under review 2022/4 5 Awaiting decision 2022/4 5 Minor revision 2022/4 7 Submit 2022/4 8 Under review 2022/4 8 Awaiting decision 2022/4 8 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Sat Apr 09 02:06:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083520, encodeId=eeee1083520a9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;基因;临床 经验分享：2021/09/21 Admin Processing 2021/09/22 Under Review 2021/10/11 Awaiting Decision 2021/10/27 催稿信 2021/10/28 杂志社回信 2021/11/05 Major Revision 2021/11/18 Admin Processing 2021/11/19 Under Review 2021/12/15 Awaiting Decision 2021/12/16 Minor Revision 2021/12/21 Admin Processing; Under Review 2021/12/22 Accept; Awaiting Production Checklist; Awaiting Assignment to Batch 2021/12/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 11:58:41 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081037, encodeId=87a1108103eb9, content=无经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Fri Dec 17 08:33:43 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579186, encodeId=c71f5e918696, content=好像收费吧shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/c2753fa357c64d2798acbad1071d0b49/e8ee71151b524eea903a818c41a35e77.png, createdBy=d87f2291021, createdName=121e7464m10暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891825, encodeId=6c378918256b, content=接受非约稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0405423428, createdName=ms7000001459311547, createdTime=Tue Oct 13 18:31:21 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585695, encodeId=4c51585695a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：初审3个月，两个审稿人，一个审稿人没意见，另一个审稿人提的意见也比较中肯，编辑给了大修，一个月后修回，二审1个月直接接收了，不收费的哦，效率还是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30785291681, createdName=1486509fm51(暂无昵称), createdTime=Mon Mar 02 11:56:00 CST 2020, time=2020-03-02, status=1, ipAttribution=)]

2021-12-17 14612008m08(暂无昵称)

无经验

78 0

[GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228518, encodeId=f78812285185e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿2个多月拒稿。投稿1天under review，外审2个月左右，中间催过一次，两个多月后拒稿，一个审稿人给了很多意见都比较严谨，还是有很大收获。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a88f5554247, createdName=ms4000000456746938, createdTime=Fri Jun 24 22:19:45 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529775, encodeId=26b4529e75d8, content=请问怎么看出来是没有送审呢？我第三天under review，第四天就awaiting decision，这样有没有外审呢？shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3991697203, createdName=LIU91, createdTime=Thu Nov 24 23:00:00 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518880, encodeId=f22c518880be, content=杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e351684614, createdName=shuozi, createdTime=Fri Jan 29 16:27:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209713, encodeId=4fdf1209e13ed, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第三次投这个杂志了，**次外审一个月拒搞，第二次直接拒搞未送审，这次终于成功接收😁😁😁 2022/2 24 Submit 2022/2 25 Under review 2022/3 15 Awaiting decision 2022/3 17 reject with invitation to resubmit 2022/3 29 Submit 2022/3 30 Under review 2022/4 5 Awaiting decision 2022/4 5 Minor revision 2022/4 7 Submit 2022/4 8 Under review 2022/4 8 Awaiting decision 2022/4 8 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Sat Apr 09 02:06:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083520, encodeId=eeee1083520a9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;基因;临床 经验分享：2021/09/21 Admin Processing 2021/09/22 Under Review 2021/10/11 Awaiting Decision 2021/10/27 催稿信 2021/10/28 杂志社回信 2021/11/05 Major Revision 2021/11/18 Admin Processing 2021/11/19 Under Review 2021/12/15 Awaiting Decision 2021/12/16 Minor Revision 2021/12/21 Admin Processing; Under Review 2021/12/22 Accept; Awaiting Production Checklist; Awaiting Assignment to Batch 2021/12/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 11:58:41 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081037, encodeId=87a1108103eb9, content=无经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Fri Dec 17 08:33:43 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579186, encodeId=c71f5e918696, content=好像收费吧shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/c2753fa357c64d2798acbad1071d0b49/e8ee71151b524eea903a818c41a35e77.png, createdBy=d87f2291021, createdName=121e7464m10暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891825, encodeId=6c378918256b, content=接受非约稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0405423428, createdName=ms7000001459311547, createdTime=Tue Oct 13 18:31:21 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585695, encodeId=4c51585695a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：初审3个月，两个审稿人，一个审稿人没意见，另一个审稿人提的意见也比较中肯，编辑给了大修，一个月后修回，二审1个月直接接收了，不收费的哦，效率还是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30785291681, createdName=1486509fm51(暂无昵称), createdTime=Mon Mar 02 11:56:00 CST 2020, time=2020-03-02, status=1, ipAttribution=)]

2019-11-01 121e7464m10暂无昵称

好像收费吧shuozi 2016-01-29 16:27:00 发表:
杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。

shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。

206 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228518, encodeId=f78812285185e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿2个多月拒稿。投稿1天under review，外审2个月左右，中间催过一次，两个多月后拒稿，一个审稿人给了很多意见都比较严谨，还是有很大收获。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a88f5554247, createdName=ms4000000456746938, createdTime=Fri Jun 24 22:19:45 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529775, encodeId=26b4529e75d8, content=请问怎么看出来是没有送审呢？我第三天under review，第四天就awaiting decision，这样有没有外审呢？shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3991697203, createdName=LIU91, createdTime=Thu Nov 24 23:00:00 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518880, encodeId=f22c518880be, content=杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e351684614, createdName=shuozi, createdTime=Fri Jan 29 16:27:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209713, encodeId=4fdf1209e13ed, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第三次投这个杂志了，**次外审一个月拒搞，第二次直接拒搞未送审，这次终于成功接收😁😁😁 2022/2 24 Submit 2022/2 25 Under review 2022/3 15 Awaiting decision 2022/3 17 reject with invitation to resubmit 2022/3 29 Submit 2022/3 30 Under review 2022/4 5 Awaiting decision 2022/4 5 Minor revision 2022/4 7 Submit 2022/4 8 Under review 2022/4 8 Awaiting decision 2022/4 8 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Sat Apr 09 02:06:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083520, encodeId=eeee1083520a9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;基因;临床 经验分享：2021/09/21 Admin Processing 2021/09/22 Under Review 2021/10/11 Awaiting Decision 2021/10/27 催稿信 2021/10/28 杂志社回信 2021/11/05 Major Revision 2021/11/18 Admin Processing 2021/11/19 Under Review 2021/12/15 Awaiting Decision 2021/12/16 Minor Revision 2021/12/21 Admin Processing; Under Review 2021/12/22 Accept; Awaiting Production Checklist; Awaiting Assignment to Batch 2021/12/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 11:58:41 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081037, encodeId=87a1108103eb9, content=无经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Fri Dec 17 08:33:43 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579186, encodeId=c71f5e918696, content=好像收费吧shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/c2753fa357c64d2798acbad1071d0b49/e8ee71151b524eea903a818c41a35e77.png, createdBy=d87f2291021, createdName=121e7464m10暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891825, encodeId=6c378918256b, content=接受非约稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0405423428, createdName=ms7000001459311547, createdTime=Tue Oct 13 18:31:21 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585695, encodeId=4c51585695a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：初审3个月，两个审稿人，一个审稿人没意见，另一个审稿人提的意见也比较中肯，编辑给了大修，一个月后修回，二审1个月直接接收了，不收费的哦，效率还是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30785291681, createdName=1486509fm51(暂无昵称), createdTime=Mon Mar 02 11:56:00 CST 2020, time=2020-03-02, status=1, ipAttribution=)]

2020-10-13 ms7000001459311547

接受非约稿综述吗

147 0

[GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228518, encodeId=f78812285185e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿2个多月拒稿。投稿1天under review，外审2个月左右，中间催过一次，两个多月后拒稿，一个审稿人给了很多意见都比较严谨，还是有很大收获。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a88f5554247, createdName=ms4000000456746938, createdTime=Fri Jun 24 22:19:45 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529775, encodeId=26b4529e75d8, content=请问怎么看出来是没有送审呢？我第三天under review，第四天就awaiting decision，这样有没有外审呢？shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 发表:: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3991697203, createdName=LIU91, createdTime=Thu Nov 24 23:00:00 CST 2016, time=2016-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518880, encodeId=f22c518880be, content=杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e351684614, createdName=shuozi, createdTime=Fri Jan 29 16:27:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209713, encodeId=4fdf1209e13ed, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第三次投这个杂志了，**次外审一个月拒搞，第二次直接拒搞未送审，这次终于成功接收😁😁😁 2022/2 24 Submit 2022/2 25 Under review 2022/3 15 Awaiting decision 2022/3 17 reject with invitation to resubmit 2022/3 29 Submit 2022/3 30 Under review 2022/4 5 Awaiting decision 2022/4 5 Minor revision 2022/4 7 Submit 2022/4 8 Under review 2022/4 8 Awaiting decision 2022/4 8 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Sat Apr 09 02:06:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083520, encodeId=eeee1083520a9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;基因;临床 经验分享：2021/09/21 Admin Processing 2021/09/22 Under Review 2021/10/11 Awaiting Decision 2021/10/27 催稿信 2021/10/28 杂志社回信 2021/11/05 Major Revision 2021/11/18 Admin Processing 2021/11/19 Under Review 2021/12/15 Awaiting Decision 2021/12/16 Minor Revision 2021/12/21 Admin Processing; Under Review 2021/12/22 Accept; Awaiting Production Checklist; Awaiting Assignment to Batch 2021/12/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 11:58:41 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081037, encodeId=87a1108103eb9, content=无经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Fri Dec 17 08:33:43 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579186, encodeId=c71f5e918696, content=好像收费吧shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, beContent=shuozi 2016-01-29 16:27:00 发表: 杂志效率很快，老板手下两个学生投稿都是5天内秒拒，未送审，转投2分多的杂志很快接收，可能纯临床的小样本研究还是不符合这个杂志的要求。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/c2753fa357c64d2798acbad1071d0b49/e8ee71151b524eea903a818c41a35e77.png, createdBy=d87f2291021, createdName=121e7464m10暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891825, encodeId=6c378918256b, content=接受非约稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0405423428, createdName=ms7000001459311547, createdTime=Tue Oct 13 18:31:21 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585695, encodeId=4c51585695a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：初审3个月，两个审稿人，一个审稿人没意见，另一个审稿人提的意见也比较中肯，编辑给了大修，一个月后修回，二审1个月直接接收了，不收费的哦，效率还是很高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30785291681, createdName=1486509fm51(暂无昵称), createdTime=Mon Mar 02 11:56:00 CST 2020, time=2020-03-02, status=1, ipAttribution=)]

2020-03-02 1486509fm51(暂无昵称)

审稿速度:3.0 | 投稿命中率:50.0
经验分享：初审3个月，两个审稿人，一个审稿人没意见，另一个审稿人提的意见也比较中肯，编辑给了大修，一个月后修回，二审1个月直接接收了，不收费的哦，效率还是很高的

195 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务